PACILLI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.268
EU - Europa 1.687
AS - Asia 965
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 20
OC - Oceania 4
Totale 6.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.227
RU - Federazione Russa 570
IT - Italia 397
SG - Singapore 307
CN - Cina 228
PL - Polonia 179
HK - Hong Kong 158
IE - Irlanda 126
BR - Brasile 101
VN - Vietnam 101
SE - Svezia 99
DE - Germania 75
FR - Francia 70
KR - Corea 60
FI - Finlandia 52
CH - Svizzera 43
IN - India 32
GB - Regno Unito 30
CA - Canada 29
JO - Giordania 28
ES - Italia 14
AR - Argentina 13
NL - Olanda 11
IQ - Iraq 8
BD - Bangladesh 6
CI - Costa d'Avorio 6
EC - Ecuador 5
AU - Australia 4
CL - Cile 4
ID - Indonesia 4
JP - Giappone 4
MX - Messico 4
NG - Nigeria 4
NP - Nepal 4
PK - Pakistan 4
UA - Ucraina 4
UZ - Uzbekistan 4
VE - Venezuela 4
CO - Colombia 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
TR - Turchia 3
AT - Austria 2
BE - Belgio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JM - Giamaica 2
MA - Marocco 2
MY - Malesia 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TW - Taiwan 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
NO - Norvegia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 6.083
Salva come PNG Salva come JPEG
Città #
Santa Clara 554
Ashburn 346
Fairfield 260
Singapore 216
Warsaw 178
Woodbridge 136
Hong Kong 135
Chandler 134
Seattle 133
Dublin 126
San Jose 112
Cambridge 106
Wilmington 96
Houston 91
Beijing 73
Seoul 60
Florence 55
Altamura 53
Milan 53
Ann Arbor 49
Lawrence 48
Los Angeles 44
Bern 43
Princeton 41
The Dalles 39
Dallas 38
Buffalo 37
Lauterbourg 27
Moscow 27
Munich 27
Ho Chi Minh City 26
Rome 26
Hanoi 25
Bremen 24
Chicago 23
Boston 22
Council Bluffs 22
New York 22
Clifton 20
Helsinki 19
Mumbai 19
San Diego 18
Turku 18
Paris 17
Shanghai 16
Atlanta 13
Barcelona 11
London 11
Orem 11
São Paulo 11
Medford 10
Montreal 10
Redondo Beach 10
Kent 9
Boardman 8
Brooklyn 7
Dearborn 7
Phoenix 7
Abidjan 6
Chennai 6
Denver 6
Figino 6
Guangzhou 6
Hillsboro 6
Pian di Scò 6
Brescia 5
Da Nang 5
Naples 5
Norwalk 5
Amsterdam 4
Belo Horizonte 4
Charlotte 4
Dong Ket 4
Falls Church 4
Frankfurt am Main 4
Fuzhou 4
Genoa 4
Jacksonville 4
Redwood City 4
Romainville 4
Salvador 4
San Francisco 4
Tashkent 4
Toronto 4
Venice 4
Verona 4
Abuja 3
Baghdad 3
Biên Hòa 3
Cagliari 3
Changsha 3
Düsseldorf 3
Faenza 3
Fiesole 3
Haiphong 3
Lima 3
Melbourne 3
Miano 3
Nairobi 3
Ninh Bình 3
Totale 3.951
Salva come PNG Salva come JPEG
Nome #
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 404
Validation of the Mayo alliance prognostic system for mastocytosis 347
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 338
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis 257
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group 254
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 239
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 238
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 235
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 228
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 228
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 214
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 213
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 210
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 206
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 204
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 201
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 197
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 195
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 172
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera 172
Novel insights into myelofibrosis pathophysiology and treatment 171
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 168
Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group 164
Prognotic Impact of Mutations in Systemic Mastocytosis 163
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms 159
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice? 157
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera 133
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients. 124
Prognostic relevance of mutations in myelofi-brosis 122
null 47
Totale 6.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022177 0 0 0 9 14 13 9 22 13 7 35 55
2022/2023725 59 153 49 51 37 100 81 47 77 6 18 47
2023/2024244 10 21 29 12 30 28 3 61 4 17 16 13
2024/20251.539 56 151 117 260 406 247 23 77 52 50 41 59
2025/20261.503 181 149 92 134 234 53 192 50 89 103 43 183
2026/2027574 71 351 109 43 0 0 0 0 0 0 0 0
Totale 6.160